• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » NeuSpera Medical lands ex-Cyberonics R&D SVP Morris for CEO | Personnel Moves

NeuSpera Medical lands ex-Cyberonics R&D SVP Morris for CEO | Personnel Moves

August 18, 2015 By Brad Perriello

MassDevice.com Personnel MovesNeuSpera Medical said it snagged the former R&D senior vice president at Cyberonics, Milton Morris, for its corner office as it gears up to raise a Series A round for its neuromodulation technology.

NeuSpera, formerly known as Vivonda Medical, is developing injectable neuromodulation devices, so called “electroceuticals,” using licensed mid-field powering technology. The Santa Clara, Calif.-based company says its implantable module is 100 times smaller than other neuromodulation devices. NeuSpera said it’s raised more than $1 million in angel funding so far.

“We are delighted to welcome Milton as NeuSpera’s president & CEO,” NeuSpera chairman Bing Yeh said in prepared remarks. “Bringing with him over 23 years of rich experience in the medical device industry, Milton is a dynamic leader and a talented executive with a proven track record of driving technology innovation and business growth. For the past several months, Milton has been working with the company as a consultant. Under his guidance, the team has made great progress and is now ready to take the next step in addressing the milestones targeted for Series A financing. I am confident that Milton has the leadership qualities and industry experience to propel NeuSpera forward.”

“I am excited to be leading NeuSpera Medical – a young, fast-moving company with a truly innovative technology,” added Morris, who was already a member of the company’s board. “It is a privilege to be in a position to positively impact human lives through medical technology – a privilege that I take seriously. NeuSpera has the opportunity to fundamentally change the way neuromodulation therapy is delivered. I look forward to realizing its great potential.”

 NuVasive taps Thermo Fisher’s Lai for IT chief
NuVasive Inc. (NSDQ:NUVA)
said it lured Thermo Fisher‘s (NYSE:TMO) vice president of IT, Johnson Lai, to be its new chief information officer.
Read more

 Check-Cap promotes Densel to CEO
Check-Cap (NSDQ:CHEK) said it named Bill Densel to replace Guy Neev as CEO. Densel was the company’s U.S. operations president. Neev is slated to stay on as a consultant through the end of 2015.
Read more

 Bone Biologics grabs La Neve for CEO, Frelick for COO
Bone Biologics said it named medtech veteran Stephen La Neve to be its new CEO, replacing interim chief Michael Schuler, and tapped Jeffrey Frelick to be its COO.
Read more

 Nephros names former Outset Medical CEO Pinto to board
Nephros (OTC:NEPH) said it named Moshe Pinto, the former CEO of Home Dialysis Plus (now Outset Medical) to its board of directors.
Read more

Filed Under: Neuromodulation/Neurostimulation Tagged With: Bone Biologics Corp., Check-Cap, Nephros, NeuSpera Medical, Nuvasive, Personnel Moves

More recent news

  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Preceptis Medical has a new CEO as it advances ear tube tech
  • FDA clears first over-the-counter cuffless blood pressure monitor
  • Mendaera wins FDA clearance for robotic needle placement
  • Johnson & Johnson seeks to have $442 million antitrust verdict tossed out

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy